Tandem Diabetes Care Gets Health Canada Approval for Expanded t:slim X2 Use

10:34 AM EST, 11/12/2026 (MT Newswires) -- Tandem Diabetes Care (TNDM) said Thursday it has received Health Canada approval for an update to its t:slim X2 insulin pump with Control-IQ+ automated insulin delivery technology. The approval adds compatibility with Abbott Laboratories' (ABT) FreeStyle Libre 3 Plus Sensor and expands the system's use to people with type 1 diabetes during pregnancy and adults with type 2 diabetes in Canada, the company said. The new sensor compatibility and expanded indications are expected to become available in Q2 2027, it added. Shares of Tandem Diabetes Care were down 2.2% and Abbott fell 1.2% in the session. Price: 18.04, Change: -0.73, Percent Change: -3.92